H Tani, S Tohyama - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
The emergence of human induced pluripotent stem cells (hiPSCs) and efficient differentiation of hiPSC-derived cardiomyocytes (hiPSC-CMs) induced from diseased …
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) offer a promising cell- based therapy for myocardial infarction. However, the presence of transitory ventricular …
P Beauchamp, CB Jackson, LC Ozhathil… - Frontiers in molecular …, 2020 - frontiersin.org
Purpose: Both cardiomyocytes and cardiac fibroblasts (CF) play essential roles in cardiac development, function, and remodeling. Properties of 3D co-cultures are incompletely …
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly used for personalised medicine and preclinical cardiotoxicity testing. Reports on hiPSC-CM …
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have the potential to remuscularize infarcted hearts but their arrhythmogenicity remains an obstacle to …
AJS Ribeiro, BD Guth, M Engwall, S Eldridge… - Frontiers in …, 2019 - frontiersin.org
Contractility of the myocardium engines the pumping function of the heart and is enabled by the collective contractile activity of its muscle cells: cardiomyocytes. The effects of drugs on …
Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) hold great potential for drug screening applications. However, their usefulness is limited by the relative …
TC Sung, HC Su, QD Ling, SS Kumar, Y Chang… - Biomaterials, 2020 - Elsevier
The current differentiation process of human pluripotent stem cells (hPSCs) into cardiomyocytes to enhance the purity of hPSC-derived cardiomyocytes requires some …
R Shi, M Reichardt, DJ Fiegle, LK Küpfer… - Cardiovascular …, 2023 - academic.oup.com
Aims Cardiotoxicity is one major reason why drugs do not enter or are withdrawn from the market. Thus, approaches are required to predict cardiotoxicity with high specificity and …